Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.

Cerebral Lesion Clinical Trial

Official title:

SOCIALBI, a Rasch Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04034875
• Other study ID #: CHUB-SOCIALBI
• Status: Completed
• Phase: N/A
• Start date: April 9, 2019
• Est. completion date: July 28, 2023

Study information

• Verified date: May 2024
• Source: Brugmann University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The incidence of aggression and violent behavior is usually reported to be high after acquired brain injury, around 54%. Behaviors with verbal agression and, less frequently, physical agressions, are described.

These behaviors may be linked to the dysfunction of the frontal lobes responsible for executive functions and complex social interactions, or to the dysfunction of the temporal structures that may also be responsible for increased aggression.

It is interesting to note that very few scales or specific questionnaires evaluate the factors and co-variables that could lead to aggressive behavior after an acquired brain injury. Such questionnaires are very rare, and none have been validated in French.

The objective of this study is to develop a questionnaire in French that aims to assess anger, hostility and aggression after acquired brain injury. The psychometric qualities of this questionnaire will be evaluated using the Rasch probabilistic model.

The development of such a tool will be of major interest for clinical practice and future clinical research.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: July 28, 2023
• Est. primary completion date: July 28, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Patients of the CHU Brugmann Hospital

• Central neurological pathology of vascular or traumatic origin, acute or chronic (known since more than one year).

Exclusion Criteria:

• Pregnant or lactating women

• Presence or antecedents of psychiatric disease

• Degenerative pathology (ex: Parkinson...)

• Antecedents of other neurologic pathologies before the acquired lesion

• Oral or written comprehension dysfunctions.

Related Conditions & MeSH terms

• Aggression
• Brain Injuries
• Cerebral Lesion

Intervention

Other:
• Questionnaire
questionnaire

Locations

Country	Name	City	State
Belgium	Brugmann University Hospital	Brussels
France	Hôpital Universitaire Pitié-Salpêtrière	Paris
France	Hôpitaux Saint Maurice	Saint-Maurice

Sponsors (1)

Lead Sponsor	Collaborator
Brugmann University Hospital

Countries where clinical trial is conducted

Belgium,  France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Questionnaire evaluation by Rasch methodology	questionnaire validity	30 minutes